Human targets of Pseudomonas aeruginosa pyocyanin

Huimin Ran, Daniel J. Hassett, Gee W. Lau

Research output: Contribution to journalArticle

Abstract

Pseudomonas aeruginosa produces copious amounts of the redoxactive tricyclic compound pyocyanin that kills competing microbes and mammalian cells, especially during cystic fibrosis lung infection. Cross-phylum susceptibility to pyocyanin suggests the existence of evolutionarily conserved physiological targets. We screened a Saccharomyces cerevisiae deletion library to identify presumptive pyocyanin targets with the expectation that similar targets would be conserved in humans. Fifty S, cerevisiae targets were provisionally identified, of which 60% have orthologous human counterparts. These targets encompassed major cellular pathways involved in the cell cycle, electron transport and respiration, epidermal cell growth, protein sorting, vesicle transport, and the vacuolar ATPase. Using cultured human lung epithelial cells, we showed that pyocyanin-mediated reactive oxygen intermediates inactivate human vacuolar ATPase, supporting the validity of the yeast screen. We discuss how the inactivation of V-ATPase may negatively impact the lung function of cystic fibrosis patients.

Original languageEnglish (US)
Pages (from-to)14315-14320
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume100
Issue numberSUPPL. 2
DOIs
StatePublished - Nov 25 2003
Externally publishedYes

Fingerprint

Pyocyanine
Pseudomonas aeruginosa
Vacuolar Proton-Translocating ATPases
Cystic Fibrosis
Lung
Saccharomyces cerevisiae
Cell Respiration
Transport Vesicles
Protein Transport
Electron Transport
Libraries
Adenosine Triphosphatases
Cell Cycle
Yeasts
Epithelial Cells
Oxygen
Growth
Infection

ASJC Scopus subject areas

  • General

Cite this

Human targets of Pseudomonas aeruginosa pyocyanin. / Ran, Huimin; Hassett, Daniel J.; Lau, Gee W.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, No. SUPPL. 2, 25.11.2003, p. 14315-14320.

Research output: Contribution to journalArticle

@article{3f8ae24a172e490bab48ddcfd63b55b9,
title = "Human targets of Pseudomonas aeruginosa pyocyanin",
abstract = "Pseudomonas aeruginosa produces copious amounts of the redoxactive tricyclic compound pyocyanin that kills competing microbes and mammalian cells, especially during cystic fibrosis lung infection. Cross-phylum susceptibility to pyocyanin suggests the existence of evolutionarily conserved physiological targets. We screened a Saccharomyces cerevisiae deletion library to identify presumptive pyocyanin targets with the expectation that similar targets would be conserved in humans. Fifty S, cerevisiae targets were provisionally identified, of which 60{\%} have orthologous human counterparts. These targets encompassed major cellular pathways involved in the cell cycle, electron transport and respiration, epidermal cell growth, protein sorting, vesicle transport, and the vacuolar ATPase. Using cultured human lung epithelial cells, we showed that pyocyanin-mediated reactive oxygen intermediates inactivate human vacuolar ATPase, supporting the validity of the yeast screen. We discuss how the inactivation of V-ATPase may negatively impact the lung function of cystic fibrosis patients.",
author = "Huimin Ran and Hassett, {Daniel J.} and Lau, {Gee W.}",
year = "2003",
month = "11",
day = "25",
doi = "10.1073/pnas.2332354100",
language = "English (US)",
volume = "100",
pages = "14315--14320",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Human targets of Pseudomonas aeruginosa pyocyanin

AU - Ran, Huimin

AU - Hassett, Daniel J.

AU - Lau, Gee W.

PY - 2003/11/25

Y1 - 2003/11/25

N2 - Pseudomonas aeruginosa produces copious amounts of the redoxactive tricyclic compound pyocyanin that kills competing microbes and mammalian cells, especially during cystic fibrosis lung infection. Cross-phylum susceptibility to pyocyanin suggests the existence of evolutionarily conserved physiological targets. We screened a Saccharomyces cerevisiae deletion library to identify presumptive pyocyanin targets with the expectation that similar targets would be conserved in humans. Fifty S, cerevisiae targets were provisionally identified, of which 60% have orthologous human counterparts. These targets encompassed major cellular pathways involved in the cell cycle, electron transport and respiration, epidermal cell growth, protein sorting, vesicle transport, and the vacuolar ATPase. Using cultured human lung epithelial cells, we showed that pyocyanin-mediated reactive oxygen intermediates inactivate human vacuolar ATPase, supporting the validity of the yeast screen. We discuss how the inactivation of V-ATPase may negatively impact the lung function of cystic fibrosis patients.

AB - Pseudomonas aeruginosa produces copious amounts of the redoxactive tricyclic compound pyocyanin that kills competing microbes and mammalian cells, especially during cystic fibrosis lung infection. Cross-phylum susceptibility to pyocyanin suggests the existence of evolutionarily conserved physiological targets. We screened a Saccharomyces cerevisiae deletion library to identify presumptive pyocyanin targets with the expectation that similar targets would be conserved in humans. Fifty S, cerevisiae targets were provisionally identified, of which 60% have orthologous human counterparts. These targets encompassed major cellular pathways involved in the cell cycle, electron transport and respiration, epidermal cell growth, protein sorting, vesicle transport, and the vacuolar ATPase. Using cultured human lung epithelial cells, we showed that pyocyanin-mediated reactive oxygen intermediates inactivate human vacuolar ATPase, supporting the validity of the yeast screen. We discuss how the inactivation of V-ATPase may negatively impact the lung function of cystic fibrosis patients.

UR - http://www.scopus.com/inward/record.url?scp=0344198520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344198520&partnerID=8YFLogxK

U2 - 10.1073/pnas.2332354100

DO - 10.1073/pnas.2332354100

M3 - Article

C2 - 14605211

AN - SCOPUS:0344198520

VL - 100

SP - 14315

EP - 14320

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - SUPPL. 2

ER -